John Cho

John Cho

Company: KSQ Therapeutics

Job title: Director, Immunobiology


De-Coding & Re-Wiring Tregs with CRISPR to Enable Next-Gen Treg Cellular Therapy 4:30 pm

Describing strategies employed by KSQ to identify novel regulators of human Tregs Utilizing in vitro and in vivo systems to model human Treg stability and persistence Engineering approaches to improve potency of Treg cellular therapyRead more

day: Day One | Track A | Afternoon

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.